The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Objectives. This review assesses the polypharmacy reduction potential of cinnamic acids (CAs) and some related compounds in managing three or more of the cluster of seven, pre- and post-type 2 diabetes mellitus (T2DM)-related features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Barre Douglas Edward, Mizier-Barre Kazimiera Amelia
Formato:	article
Lenguaje:	EN
Publicado:	Sciendo 2020
Materias:	cinnamic acids and related compounds type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/06705b0aa79147eea4938b0cd749301c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:06705b0aa79147eea4938b0cd749301c
record_format	dspace
spelling	oai:doaj.org-article:06705b0aa79147eea4938b0cd749301c2021-12-02T16:40:25ZThe polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus1336-032910.2478/enr-2020-0017https://doaj.org/article/06705b0aa79147eea4938b0cd749301c2020-04-01T00:00:00Zhttps://doi.org/10.2478/enr-2020-0017https://doaj.org/toc/1336-0329Objectives. This review assesses the polypharmacy reduction potential of cinnamic acids (CAs) and some related compounds in managing three or more of the cluster of seven, pre- and post-type 2 diabetes mellitus (T2DM)-related features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation, and inflammation).Barre Douglas EdwardMizier-Barre Kazimiera AmeliaSciendoarticlecinnamic acids and related compoundstype 2 diabetes mellituscentral obesityhyperglycemiahypertensiondyslipidemiapro-thrombosisoxidation and inflammationDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 54, Iss 2, Pp 137-155 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	cinnamic acids and related compounds type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665
spellingShingle	cinnamic acids and related compounds type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665 Barre Douglas Edward Mizier-Barre Kazimiera Amelia The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
description	Objectives. This review assesses the polypharmacy reduction potential of cinnamic acids (CAs) and some related compounds in managing three or more of the cluster of seven, pre- and post-type 2 diabetes mellitus (T2DM)-related features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation, and inflammation).
format	article
author	Barre Douglas Edward Mizier-Barre Kazimiera Amelia
author_facet	Barre Douglas Edward Mizier-Barre Kazimiera Amelia
author_sort	Barre Douglas Edward
title	The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
title_short	The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
title_full	The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
title_fullStr	The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
title_full_unstemmed	The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
title_sort	polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
publisher	Sciendo
publishDate	2020
url	https://doaj.org/article/06705b0aa79147eea4938b0cd749301c
work_keys_str_mv	AT barredouglasedward thepolypharmacyreductionpotentialofcinnamicacidsandsomerelatedcompoundsinpreandpostonsetmanagementoftype2diabetesmellitus AT mizierbarrekazimieraamelia thepolypharmacyreductionpotentialofcinnamicacidsandsomerelatedcompoundsinpreandpostonsetmanagementoftype2diabetesmellitus AT barredouglasedward polypharmacyreductionpotentialofcinnamicacidsandsomerelatedcompoundsinpreandpostonsetmanagementoftype2diabetesmellitus AT mizierbarrekazimieraamelia polypharmacyreductionpotentialofcinnamicacidsandsomerelatedcompoundsinpreandpostonsetmanagementoftype2diabetesmellitus
_version_	1718383554318041088

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Ejemplares similares